Press releases in 2021

22. 12. 2021 |
2021 was a difficult year, but it brought about numerous good news for cancer patients. The results of the successful scientific research work performed by dedicated researchers are a source ...
8. 12. 2021 |
Novartis in Slovenia celebrates 75 years since the founding of Lek, the first modern pharmaceutical company in Slovenia, 25 years of Novartis and 15 years since the approval of the ...
7. 12. 2021 |
Sandoz, a division ofNovartis and a leading global company in generics and biosimilars crowned its scientists with prestigious research and development awards. As in previous years, researchers from Sandoz Development ...
29. 11. 2021 |
On Friday, November 26, the Solids Lendava signed a scholarship agreement with first-year students Neja Preložnik and Blaž Vidovič at the Faculty of Chemistry and Chemical Technology of the University ...
26. 11. 2021 |
Today marks Iron Deficiency Day, which focuses on recognizing the importance of iron for our health and raising awareness about it. More than 1.6 billion2 people  worldwide suffer from iron ...
3. 11. 2021 |
November is traditionally focusing on health-related issues, experienced by men, especially of prostate cancer, and in recent years also to mental health and suicide. Prostate cancer is the most commonly ...
21. 10. 2021 |
Novartis announced today that it has signed an initial agreement to leverage its manufacturing capacity and capabilities to address the COVID-19 pandemic by expanding its support of the fill and ...
13. 10. 2021 |
This year's national awards for innovation were presented as part of the Innovation Day hosted by the Chamber of Commerce and Industry of Slovenia on October 12, 2021. Lek, which ...
1. 10. 2021 |
Novartis Slovenia hosted 36 of the most promising science, economics and engineering students from the region and beyond at the 11th BioCamp. A panel of experts from Novartis and representatives ...
27. 9. 2021 |
This year's BioCamp began with welcome addresses by Robert Ljoljo, President of the Board of Management of Lek and President of Novartis Slovenia, and Jerh Collins, Chief Culture Officer at ...
22. 9. 2021 |
In the campaign to raise awareness of blood diseases, enabled by Novartis, today we raise awareness of an early diagnosis of primary immunethrombocytopenia (ITP), as today begins the Global ITP Awareness ...
21. 9. 2021 |
Novartis sites inSlovenia have a long tradition of energy management, contributing to their competitiveness. Robert Ljoljo, President of the Managent Board of Lek d.d. and Novartis Country President Slovenia, points ...
20. 9. 2021 |
Miha Homar, Ph.D., a senior scientist from the Development Center Slovenia, received the 2021 Minařik Award bestowed by the Slovenian Pharmaceutical Society. He received the award for his longstanding and ...
17. 9. 2021 |
The humanitarian organization Association of Patients with Blood Diseases Slovenia has been providing diverse support and professional assistance to its members, patients, and patients’ relatives for 26 years in cooperation with healthcare ...
15. 9. 2021 |
In the campaign to raise awareness of blood diseases during the World Lymphoma Awareness Day we emphasize the importance of an early diagnosis of this disease, which is the most ...
10. 9. 2021 |
Lek,  which is part of Novartis in Slovenia, received an award from the National  Institute of Chemistry for quality participation in research. The beginnings of  one of the long-standing and ...
8. 9. 2021 |
Each year in Slovenia we notice an increasing incidence of blood disorders. The symptoms of these disorders are difficult to recognize and appear in all age groups, which is why ...
24. 8. 2021 |
The Novartis scientific awards pay tribute to those individuals or teams who have demonstrated special commitment and achievements within their work, thus contributing importantly to the R&D activity of the ...
5. 7. 2021 |
Newspaper Delo published an interesting interview with the President of the  Management Board of Lek and the Novartis Country president Slovenia, Robert Ljoljo,  in the Saturdays’ supplement, on July 3rd, ...
30. 6. 2021 |
Novartis plans to be fully carbon neutral across the value chain as well as being water and plastic neutral by 2030*. Employees are involved in further building the environmental sustainability ...
24. 6. 2021 |
Although the Covid-19 pandemic has taken over our lives this year, it is becoming clear that diseases such as Covid-19 cannot be addressed and considered individually, as they are closely ...
23. 6. 2021 |
The interdisciplinary team consisting of three Novartis associates in Slovenia, Miha Homar, PhD, Senior Researcher, Leon Rižner, Scientist, and Iva Pilko, P&O specialist, in collaboration withJakob Gajšek, Chief Executive of ...
4. 6. 2021 |
Novartis today announced that alpelisib, which is used in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor positive, human epidermal growth factor receptor-2 negative ...
4. 6. 2021 |
At both the global and national levels, Novartis is daily committed to creating an inclusive environment that values diversity and enables associates to be true to themselves, regardless of gender, ...
17. 5. 2021 |
Today, the Ljubljana Town Hall hosted a LGBT-Friendly certificate ceremony. The LGBT-Friendly certificates are awarded by the City of Ljubljana to organizations committed to creating an inclusive environment for LGBT ...
10. 5. 2021 |
On the occasion of the European Heart Failure Days, which we celebrate in May, we at Novartis join the awareness activities for this most widespread cardiovascular disease. This year, among ...
5. 5. 2021 |
In the autumn, Novartis in Slovenia will once again organize the BioCamp, a scientific event intended to bring together top students, academia and industry. The award-winning HR practice offers young ...
22. 4. 2021 |
Lek is the recipient of the prestigious title ‘the most reputable employer’, presented by the recruitment portal MojeDelo.com. The survey involves experts from academia and business, as well as students ...
21. 4. 2021 |
In mid-April, the first Pharma Data Science Hack was completed, carried out by Novartis in Slovenia in cooperation with the company  Axiologo. The competition was  intended for experienced data scientists ...
8. 4. 2021 |
The introduction of an electric van transporting samples between Ljubljana and Mengeš and the installation of trial charging stations at both sites are new steps by Novartis in Slovenia to ...
7. 4. 2021 |
Novartis in Slovenia’s project  Vision that introduces mixed reality technology, won the Innovation category of the Best of the Best 2021 project, with which AmCham Slovenia recognizes best  business practices ...
24. 3. 2021 |
At today’s Golden Thread Award ceremony, Novartis in Slovenia received the Golden Practice Award bestowed by the Slovenian media company Dnevnik for innovative and efficient human resource practice. The award ...
18. 3. 2021 |
Modern biological treatments are the therapy of the future, since some of them, in addition to being effective and safe, also allow patients to administer them at home, was the ...
4. 3. 2021 |
Novartis in Slovenia has obtained the LGBT Friendly Company certificate, which is awarded by the Ljubljana City Municipality. Novartis has long nurtured a culture of diversity and inclusion, which is ...
3. 3. 2021 |
On Wednesday, March 3, President of the Board of Management of Lek and Novartis Country President Slovenia Robert Ljoljo participated at the business breakfast hosted by American Chamber of Commerce ...
1. 3. 2021 |
The last day of February marks the Rare Disease Day. Rare diseases aresome of the most complex and scientifically challenging diseases to tackle.Despite being rare, according to EURORDIS, there are ...
24. 2. 2021 |
Eva Podgoršek, Head Health, Safety and Environment at Novartis in Slovenia, said on the occasion of obtaining the 13th Responsible Care® certificate: ''At the forefront of the Responsible Care initiative ...
15. 2. 2021 |
European Commission (EC) has approved Novartis’ innovative medicine inclisiran for the treatment of adults with hypercholesterolemia or mixed dyslipidemia for patients with elevated LDL-C cholesterol, despite treatment with other lipid-lowering ...
3. 2. 2021 |
The Slovenian Press Agency published an article on Sandoz's business results in 2020 and the challenges they faced due to the COVID-19 pandemic, on the transformation of Sandoz and also ...
26. 1. 2021 |
Novartis in Slovenia, operating through Lek d. d., Novartis Pharma Services Inc. Branch office Slovenia and Sandoz d. d., achieved ambitious goals in 2020 despite the challenging situation posed by ...
5. 1. 2021 |
Novartis in Slovenia organized the sixth Novartis career breakfast, this time as an online event, which was attended by 300 experts in the natural sciences and other fields. On12 thematic ...